# | ||||
---|---|---|---|---|
1 | CANCERPATHWAYS Developmental Molecular Pathways in Drosophila as a Model for Human Cancer | 2008 | 4˙438˙623.00 | 2˙995˙295.00 |
2 | RIBOGENES The role of noncoding RNA in sense and antisense or orientation in epigenetic control of rRNA genes | 2009 | 831˙756.00 | 831˙756.00 |
3 | NCRNALUNGCANCER Function of Non-coding RNAs in Lung Cancer | 2009 | 100˙000.00 | 100˙000.00 |
4 | MAST-CELL-FUNCTIONS Genetically defined and selectively mast cell-deficient mouse model to unravel the immunological roles of mast cells | 2009 | 1˙880˙000.00 | 1˙880˙000.00 |
5 | ROS IN CELL FATE Influence of oxidants on cell fate determination by use of a GFP coupled redox sensor | 2009 | 158˙694.00 | 158˙694.00 |
6 | TOR-AA Amino acid sensing by TOR | 2010 | 1˙499˙279.00 | 1˙499˙279.00 |
7 | DIABAT Recruitment and activation of brown adipocytes as preventive and curative therapy for type 2 diabetes | 2011 | 9˙958˙633.00 | 5˙999˙998.00 |
8 | THERAVAC Development of a therapeutic HPV vaccine via target epitope identification by mass spectrometry | 2011 | 100˙000.00 | 100˙000.00 |
9 | MIRNAAGODDR Regulation of Argonaute-2 and miRNA-dependent mRNA decay in response to oxidative stress and DNA damage | 2012 | 167˙390.00 | 167˙390.00 |
10 | MREXCITE Unlocking the potential of ultra-high-field MRI through manipulation of radiofrequency excitation fields in human tissue | 2012 | 2˙099˙996.00 | 2˙099˙996.00 |
11 | SELF-TOLERANCE "Generating self-antigen diversity in the thymus: from gene expression patterns in single cells to the system level, an integrative approach" | 2012 | 2˙014˙560.00 | 2˙014˙560.00 |
12 | SYNGENE Global Mapping of Synthetic Genetic Interactions in Drosophila | 2012 | 2˙500˙000.00 | 2˙500˙000.00 |
13 | BONEMETTNC Analysis of Tenascin C function in breast cancer metastasis to bone | 2013 | 100˙000.00 | 100˙000.00 |
14 | TIPC_TIL_IP T-cell based immunotherapy in pancreatic cancer - basic concepts and pre-clinical development | 2013 | 100˙000.00 | 100˙000.00 |
15 | IACT Immunostimulatory Agonist antibodies for Cancer Therapy | 2013 | 8˙227˙907.00 | 5˙995˙747.00 |
16 | IMMR Mechanisms of Mismatch repair inactivation and identification of genes suppressing mutations | 2014 | 100˙000.00 | 100˙000.00 |
17 | KP TRANSPORT Identifying and characterising transmembrane transporters of tryptophan and kynurenine in normal and cancerous brain tissue | 2014 | 161˙968.00 | 161˙968.00 |
18 | RANKL_OPG The RANK-Axis in Breast Cancer: A comprehensive prospective evaluation of promising novel biomarkers | 2015 | 168˙794.00 | 168˙794.00 |
L'Ente deutsches krebsforschungszentrum partecipato anche in questi progetti.